Overview

Determining the Effects of Observed and Self-Administered Drug Regimens in HIV Infected Adults

Status:
Completed
Trial end date:
2012-09-01
Target enrollment:
Participant gender:
Summary
Highly active antiretroviral therapy (HAART) has led to better health and survival rates among people with HIV/AIDS. The purpose of this study was to measure the effect of trained partner supervision when taking medication versus self-administered therapy in HIV infected participants. These participants have had their first virologic failure on a non-nucleoside reverse transcriptase inhibitor (NNRTI)-based HAART regimen and were starting a protease inhibitor (PI)-based HAART regimen at study entry.
Phase:
N/A
Details
Lead Sponsor:
AIDS Clinical Trials Group
Collaborator:
National Institute of Allergy and Infectious Diseases (NIAID)
Treatments:
Emtricitabine
Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination
Lopinavir
Reverse Transcriptase Inhibitors
Ritonavir
Tenofovir
Zidovudine